Back to Search
JULIE JOHNSON, D.C.
D.C.
Chiropractor
NPI: 1366691131IndividualAccepts Medicare
Specialties, Licenses & Credentials
ChiropractorPrimary
Chiropractor
Code: 111N00000X
06391(IA)
CMS Specialties
PrimaryCHIROPRACTIC
Education
PALMER COLLEGE CHIROPRACTIC - DAVENPORT
Class of 2000
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (20)
Integrated metabolomics analysis reveals mechanistic insights into variability in blood pressure response to thiazide diuretics and beta blockers.
PMID 38747311·Clin Transl Sci·2024
2-rct
Circulating microRNA Biomarkers of Thiazide Response in Hypertension.
PMID 38353215·J Am Heart Assoc·2024
8-other
Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated Hypertension.
PMID 30753254·Am J Hypertens·2019
4-observational
Genome-Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β-Blockers.
PMID 29478026·J Am Heart Assoc·2018
1-meta
Genome Wide Association Study Identifies theLocus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients.
PMID 29523524·J Am Heart Assoc·2018
1-meta
Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studies.
PMID 29925376·BMC Med Genomics·2018
8-other
Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).
PMID 29650764·Circ Genom Precis Med·2018
4-observational
Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics.
PMID 29288159·J Am Heart Assoc·2017
8-other
Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
PMID 29097388·J Am Heart Assoc·2017
4-observational
Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response.
PMID 28115488·Circ Cardiovasc Genet·2017
4-observational
Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
PMID 23400010·Pharmacogenomics J·2014
1-meta
Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide.
PMID 25202885·Pharmacotherapy·2014
4-observational
Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate.
PMID 24637943·Clin Pharmacol Ther·2014
8-other
Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose?
PMID 24627569·Circ Cardiovasc Genet·2014
2-rct
Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertension.
PMID 23886594·Am J Hypertens·2014
2-rct
Pharmacometabolomics reveals racial differences in response to atenolol treatment.
PMID 23536766·PLoS One·2013
8-other
Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression.
PMID 22350108·Pharmacogenomics J·2013
8-other
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.
PMID 23353631·J Hypertens·2013
4-observational
Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol.
PMID 22089105·Am J Hypertens·2012
4-observational
Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.
PMID 22440088·J Transl Med·2012
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1000 BRADY ST
DAVENPORT, IA 52803 - Phone
- (563) 884-5628
Quick Facts
- NPI
- 1366691131
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 26
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile